Lexology July 26, 2022
DLA Piper

Telemedicine companies, beware: on July 20, 2022, the United States Department of Health and Human Services, Office of Inspector General (OIG) issued a new Special Fraud Alert targeting arrangements between practitioners and purported telemedicine companies, signaling a heightened focus by the government on fraud in the telemedicine industry.

While OIG drafted the alert broadly to apply to telehealth, telemedicine, and telemarketing services (collectively referred to in the Alert as Telemedicine Companies), the agency highlighted arrangements whereby practitioners order or prescribe a federally reimbursable item and/or service for patients they never examine or meaningfully assesses to determine whether such item is or service is medically necessary. OIG remarked that these arrangements commonly involve Telemedicine Companies paying practitioners on a per-click basis...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Digital Health, Govt Agencies, Health IT, HHS, OIG, Provider, Technology, Telehealth
100+ organizations ask Trump administration to make telehealth controlled substance prescribing permanent
Trump administration, Congress are working out details on telehealth flexibilities extension: ATA
Are Telehealth Reimbursement Policies Strangling FQHCs?
Doctors and patients are calling for more telehealth. Where is it?
The value of specialized telehealth services

Share This Article